Does Dr. MUNA ABUERREISH have financial conflicts of interest?

Dr. MUNA ABUERREISH (MD) has received a total of $1,307 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,307 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MUNA ABUERREISH?

According to CMS Open Payments data, Dr. MUNA ABUERREISH received funding from GILEAD SCIENCES ($271), VIIV HEALTHCARE COMPANY ($248), and JANSSEN BIOTECH ($213).

Does Dr. MUNA ABUERREISH receive research grants or speaking fees?

Dr. MUNA ABUERREISH has received $1,307 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MUNA ABUERREISH

MDReal-Time Hydrated

Specialty: Internal Medicine, Infectious Disease

Practice Location: KANSAS CITY, MO 64111

NPI Number: 1790870020

LIFETIME INDUSTRY VALUE

$1,307

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABUERREISH is a verified Internal Medicine, Infectious Disease practitioner based in KANSAS CITY, MO.

Between 2021 and 2024, Dr. ABUERREISH had an overall industry promotional and research financial footprint of $1,307 as recorded in the federal CMS Open Payments database.

$1,307 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABUERREISH's primary funding source is GILEAD SCIENCES, which accounts for $271 (representing 20.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GILEAD SCIENCES

Rank 1

$271

20.8%

VIIV HEALTHCARE COMPANY

Rank 2

$248

19%

JANSSEN BIOTECH

Rank 3

$213

16.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.